IDIBAPS researchers have reviewed the role of fibroblasts, a type of cell found in the liver, in the progression of liver cancer, both hepatocellular carcinoma and cholangiocarcinoma.
Read moreResearchers from IDIBELL, CIC bioGUNE and CIBEREHD discover that a protein called NOX4, which was previously thought to cause cell death, can also help tumor growth. The study published in the journal...
Read moreImmunotherapy has revolutionized the treatment of hepatocellular carcinoma. Researchers from the Hospital Clínic-IDIBAPS have published a review in the journal Nature Reviews – Clinical Oncology in...
Read moreNabil Djouder, lead researcher of the Growth Factors, Nutrients and Cancer Group at the Spanish National Cancer Research Centre (CNIO), is receiving funding from the Spanish Association Against Cancer...
Read moreResearchers at IDIBAPS have led a study, published in the journal Gastroenterology, in which they analyzed the clinical trials published in the past 20 years on hepatocellular carcinoma (2000-2020) an...
Read moreIDIBAPS researchers have drafted a molecular map of the most common type of liver cancer, hepatocellular carcinoma, when the origin is fatty liver disease or nonalcoholic steatohepatitis.
Read moreResearchers from the Liver Disease Laboratory at CIC bioGUNE, a member of the Basque Research & Technology Alliance (BRTA), have described a new microRNA, a gene expression regulator molecule, which d...
Read moreA work coordinated by Isabel Fabregat – group leader of TGF-β and Cancer group at IDIBELL and CIBEREHD – University of Barcelona – studies the reprogramming of lipid metabolism and provides new...
Read moreAn article published in the journal Nature suggests that immunotherapy is effective in patients with HCC of viral origin but does not increase survival of patients with HCC caused by alcohol abuse or ...
Read more